Vaxart's total assets for Q1 2025 were $158.56M, a decrease of -4.71% from the previous quarter. VXRT total liabilities were $112.94M for the fiscal quarter, a 5.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.